Cargando…

Racial differences in atrial fibrillation-related strokes and mortality

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND AND AIMS: Adverse outcomes associated with atrial fibrillation (AF) in Asians have not been fully elucidated. In a patient-level comparative analysis of UK Biobank and Korean National Health Insurance Service-Health Screening data,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, D S, Yang, P S, Kim, D H, Jang, E S, Yu, H T, Kim, T H, Sung, J H, Pak, H N, Lee, M H, Lip, G Y, Joung, B Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	10.5.1 - Oral Anticoagulation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207638/ http://dx.doi.org/10.1093/europace/euad122.210

Ejemplares similares

Racial differences in atrial fibrillation-related bleeding and mortality
por: Kang, D S, et al.
Publicado: (2023)

Should we shift warfarin to non-vitamin K antagonist oral anticoagulants for patients with atrial fibrillation staying well on warfarin for years?
por: Chao, T, et al.
Publicado: (2023)

Optimal anticoagulation intensity with warfarin for the prevention of thromboembolism with minimal bleeding in Asian patients with atrial fibrillation: multi-center, randomized controlled trial
por: Lee, K H, et al.
Publicado: (2023)

Baseline characteristics of edoxaban treatment in routine clinical practice for patients with non-valvular atrial fibrillation in China (ETNA-AF-China)
por: Guo, X Y, et al.
Publicado: (2023)

Omitting transesophageal echocardiography before catheter ablation of atrial fibrillation or left sided atrial tachycardia in patients on oral anticoagulation
por: Maslova, V, et al.
Publicado: (2023)

Impact of concomitant proton pump inhibitor during oral anticoagulant treatment
por: Lee, K N, et al.
Publicado: (2023)

Long-term effectiveness and safety of non-vitamin K antagonist anticoagulant in real world practice
por: Roh, S Y, et al.
Publicado: (2023)

How good is time-in-therapeutic-range defined warfarin treatment compared to standard dose direct oral anticoagulants? Incidence of stroke in atrial fibrillation in a nationwide registry study
por: Lehto, M, et al.
Publicado: (2023)

Identification of a real-world clinical model associated with atrial fibrillation in a large french primary care database
por: Sabouret, S P F, et al.
Publicado: (2023)

The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study
por: Grymonprez, M, et al.
Publicado: (2023)

Immune modulating drugs and oral anticoagulation in kidney transplant recipients: comparison of direct oral anticoagulants versus antagonist of vitamin-k. results from a multicenter prospective study
por: Santoro, F, et al.
Publicado: (2023)

Associations of general and abdominal obesity, and genetic risk with atrial fibrillation: longitudinal analyses in the UK biobank study
por: Choi, S, et al.
Publicado: (2023)

Renal outcomes of early rhythm control in patients with atrial fibrillation and chronic kidney disease
por: Kim, D, et al.
Publicado: (2023)

Statin use improves the outcomes in patients with atrial fibrillation: A population-based study
por: Huang, J, et al.
Publicado: (2023)

Implementation of In-Clinic SARS-CoV-2 Vaccination in Advanced Heart Failure, Lung Disease, and Transplant Clinic
por: Mathai, S.K., et al.
Publicado: (2022)

Morphology-Voltage-P-wave-duration (MVP) score to select patients for continuous atrial fibrillation screening to prevent stroke
por: Xing, L Y, et al.
Publicado: (2023)

How different very late recurrence of atrial fibrillation 5 years after catheter ablation?
por: Choi, S, et al.
Publicado: (2023)

Long term outcome in patients who refused radiofrequency ablation for atrial fibrillation
por: Kim, S, et al.
Publicado: (2023)

Left common trunkus pulmonary veins have genetic background and poor rhythm outcome after atrial fibrillation catheter ablation
por: Choi, S, et al.
Publicado: (2023)

Effect of right and left-sided programmed atrial extrasystoles on conduction across Bachmanns Bundle and initiation of atrial fibrillation
por: Van Schie, M S, et al.
Publicado: (2023)

Role of Direct Oral Anticoagulants for Post-operative Venous Thromboembolism Prophylaxis
por: Tun, Han Naung, et al.
Publicado: (2022)

Impact of sleep apnea on left atrial remodeling and stroke risk factors
por: Kim, D, et al.
Publicado: (2023)

Systolic, diastolic blood pressure and pulse pressure and risk of stroke in young aged patients with atrial fibrillation
por: Lee, S R, et al.
Publicado: (2023)

Using computed tomogram atrial myocardial thickness maps in high-power short-duration radiofrequency pulmonary vein isolation: a prospective randomized clinical study
por: Hwang, T, et al.
Publicado: (2023)

Usefulness of simultaneous isolation of the coronary sinus and the left atrial inferior wall for persistent atrial fibrillation refractory to box isolation
por: Yamauchi, Y, et al.
Publicado: (2023)

Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
por: Park, Y, et al.
Publicado: (2023)

Cardioversion strategy impacts quality of rate control during recurrences of atrial fibrillation
por: Van Der Velden, R, et al.
Publicado: (2023)

The Elevation of LIVER Enzymes in Patients with Atrial Fibrillation and COVID-19 Is a Marker of Bad Evolution and Mortality
por: Cerezo Manchado, Juan Jose, et al.
Publicado: (2020)

Left atrial Strain as a predictor of atrial fibrillation recurrence after catheter ablation
por: Blyalova, D, et al.
Publicado: (2023)

Progression and regression in the left atrial substrate in patients with atrial fibrillation: the PROGRESS-AF study
por: Marcon, L, et al.
Publicado: (2023)

Genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation
por: Park, J W, et al.
Publicado: (2023)

Atrial fibrillation and in-hospital mortality in Covid-19 patients
por: Kotadia, I, et al.
Publicado: (2023)

Impact of catheter ablation for persistent atrial fibrillation with heart failure, compared to preserved and reduced ejection fraction
por: Inamura, Y, et al.
Publicado: (2023)

Evaluation of redo procedures in blanking period following atrial fibrillation catheter ablation
por: Coteli, C, et al.
Publicado: (2023)

Outcomes associated with sodium glucose co-transporter 2 inhibitors in anticoagulated atrial fibrillation patients
por: Fawzy, A M, et al.
Publicado: (2023)

Atrial contractile and electrical remodeling is associated with more complex conduction patterns in patients without history of atrial fibrillation: a high-density epicardial mapping study
por: Kawczynski, M, et al.
Publicado: (2023)

Characterization of atrial substrate to predict AF ablation success
por: Bergonti, M, et al.
Publicado: (2023)

Confinement national lors de la crise sanitaire liée au Sars-Cov2 : quels impacts sur l'activité et la mortalité des résections digestives électives ?
por: Challine, A., et al.
Publicado: (2022)

Les inhibiteurs du système rénine-angiotensine et la mortalité par COVID-19 : une cohorte prospective de 1160 patients hypertendus, et revue de littérature
por: Gault, N., et al.
Publicado: (2021)

Pulmonary vein isolation and additional selective ablation of low voltage areas and atrial late potentials for persistent atrial fibrillation (SOLVE-AF-Study)
por: Jadidi, A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_je0n96l63tquub4mllvthr1vkn